Nearly 800 people were ring vaccinated on an emergency basis with VSV-EBOV when another Ebola outbreak occurred in Guinea in March 2016. In 2017, in the face of a new outbreak of Ebola in the Democratic Republic of the Congo, the Ministry of Health approved the vaccine's emergency use, but it was not immediately deployed. Effectiveness In April 2019, following a large-scale ring-vaccination scheme in the DRC outbreak, the WHO published the preliminary results of its research, in association with the DRC's Institut National pour la Recherche Biomedicale, into the effectiveness of the ring vaccination program, stating that the<unk><unk> -GP vaccine had been 97.5% effective at stopping Ebola transmission, relative to no vaccination.
RVSV-ZEBOV vaccine
Zika virus vaccine
MRNA vaccine
V451 vaccine
Ebola vaccine
Rabies vaccine
Malaria vaccine
Pipeline vaccine